Climb Bio, Inc. (CLYM)
7.15
-0.23
(-3.12%)
USD |
NASDAQ |
Feb 27, 16:00
7.17
+0.02
(+0.28%)
Pre-Market: 20:00
Climb Bio Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -77.20M |
| Fortress Biotech, Inc. | 15.07M |
| Oramed Pharmaceuticals, Inc. | -0.3928M |
| Lyell Immunopharma, Inc. | 50.00M |
| PepGen Inc. | 108.05M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.14M |
| Cash from Investing (Quarterly) | 15.26M |
| Free Cash Flow | -44.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1801 |
| Free Cash Flow to Equity (Quarterly) | -12.19M |
| Free Cash Flow to Firm (Quarterly) | -12.25M |
| Free Cash Flow Yield | -9.20% |